Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Episurf Medical ABEPSFF 42 3-Year EBITDA Growth Rate is 28.40% as of Mar. 2026, which is 1793% above its 10-year median of 1.50. GuruFocus rates EPSFF with a GF Score™ of 42/100 and a GF Value™ of $0.15. The stock has 7 warning signs investors should review. Among 690 Medical Devices & Instruments companies, Episurf Medical AB ranks better than 75.36% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 28.40% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 16.30% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 26.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Episurf Medical AB was 44.00% per year. The lowest was -141.60% per year. And the median was 1.50% per year.
Episurf Medical AB (OTCPK:EPSFF) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Episurf Medical AB 3-Year EBITDA Growth Rate Related Terms
EPSFF vs ABT, SYK, MDT: 3-Year EBITDA Growth Rate Comparison
For the Medical Devices subindustry, Episurf Medical AB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Episurf Medical AB 3-Year EBITDA Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Episurf Medical AB's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Episurf Medical AB's 3-Year EBITDA Growth Rate falls into.
Episurf Medical AB 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 28.40% mean?
Episurf Medical AB (EPSFF) has a 3-Year EBITDA Growth Rate of 28.40% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Episurf Medical AB and its competitors. This is 1793% above median its historical median of 1.50. According to the industry distribution chart, Episurf Medical AB ranks #170 out of 690 companies in the Medical Devices & Instruments industry, placing it in the top 24.6%.
Is Episurf Medical AB's 3-Year EBITDA Growth Rate too high?
Episurf Medical AB's current 3-Year EBITDA Growth Rate of 28.40% is 1793% above median its 10-year median of 1.50. The Medical Devices & Instruments industry median 3-Year EBITDA Growth Rate is 8.35. Episurf Medical AB's value of 28.40% is 240.1% above this industry median. Based on the distribution chart, Episurf Medical AB ranks #170 out of 690 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Episurf Medical AB has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Episurf Medical AB's 3-Year EBITDA Growth Rate compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Episurf Medical AB ranks #170 out of 690 companies for 3-Year EBITDA Growth Rate. This places Episurf Medical AB in the top 25% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 8.35. Episurf Medical AB's value of 28.40% is 240.1% above this benchmark. While the company's 10-year median is 1.50 vs. the industry median of 8.35, Episurf Medical AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EBITDA Growth Rate among Medical Devices & Instruments companies is 8.35, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Episurf Medical AB's current 3-Year EBITDA Growth Rate of 28.40% is 240.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Episurf Medical AB and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EBITDA Growth Rate is 8.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Episurf Medical AB's current 3-Year EBITDA Growth Rate is 28.40%, which is 1793% above median its own 10-year median of 1.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Episurf Medical AB stock overvalued right now?
Episurf Medical AB (EPSFF) has a current 3-Year EBITDA Growth Rate of 28.40%. The stock's GF Value™ is $0.15, compared to a current price of $0.18 — trading 21.2% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 28.40%, which is 1793% above median its 10-year median of 1.50 and 240.1% above the Medical Devices & Instruments industry median of 8.35. Episurf Medical AB's overall GF Score™ is 42/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Episurf Medical AB (EPSFF), the current 3-Year EBITDA Growth Rate is 28.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Episurf Medical AB (EPSFF) Overvalued in 2026?
Based on GuruFocus' analysis, Episurf Medical AB stock appears to be overvalued.
The current stock price of $0.18 is trading 21.2% above its estimated GF Value™ of $0.15.
Key valuation signals for EPSFF:
3-Year EBITDA Growth Rate: 28.40% (1793% above median its 10-year median of 1.50)
GF Value™: $0.15 vs. price of $0.18 (21.2% above fair value)
Industry Position: 240.1% above the Medical Devices & Instruments median (#170 of 690)
No single metric tells the full story. See the EPSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Episurf Medical AB is a medical device company. The company develops, manufactures, and commercializes solutions for the repair of the local cartilage damage in human joints. Its first patient-specific product portfolio, the knee portfolio, consists of the existing products Episealer Condyle Solo and Episealer Trochlea Solo, Episealer Femoral Twin, Epiguide MOS, and Epioscopy. Episealer Patellofemoral System for the treatment of osteoarthritis limited to thepatellofemoral part of the knee joint. The company is forming a new strategic business segment through the acquisition of real estate assets.
42GF Score
Get the complete analysis for EPSFF
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EPSFF has been successfully added to your 
